Your browser is no longer supported. Please, upgrade your browser.
Settings
GH Guardant Health, Inc. daily Stock Chart
GH [NASD]
Guardant Health, Inc.
Index- P/E- EPS (ttm)-0.83 Insider Own6.20% Shs Outstand94.38M Perf Week0.50%
Market Cap8.50B Forward P/E- EPS next Y-1.12 Insider Trans-62.36% Shs Float89.81M Perf Month-2.18%
Income-77.30M PEG- EPS next Q-0.38 Inst Own70.80% Short Float3.13% Perf Quarter-2.88%
Sales245.20M P/S34.65 EPS this Y15.70% Inst Trans-10.94% Short Ratio2.75 Perf Half Y9.09%
Book/sh8.32 P/B10.29 EPS next Y20.60% ROA-8.10% Target Price110.00 Perf Year-22.38%
Cash/sh5.24 P/C16.34 EPS next 5Y29.30% ROE-9.60% 52W Range55.90 - 112.21 Perf YTD9.56%
Dividend- P/FCF- EPS past 5Y- ROI-10.10% 52W High-23.71% Beta-
Dividend %- Quick Ratio7.10 Sales past 5Y- Gross Margin68.30% 52W Low53.15% ATR3.77
Employees622 Current Ratio7.40 Sales Q/Q83.90% Oper. Margin-38.20% RSI (14)54.11 Volatility5.98% 4.47%
OptionableYes Debt/Eq0.00 EPS Q/Q3.10% Profit Margin-31.50% Rel Volume2.34 Prev Close82.75
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout- Avg Volume1.03M Price85.61
Recom1.20 SMA202.66% SMA503.07% SMA2009.19% Volume2,396,372 Change3.46%
Jun-12-20Initiated BTIG Research Buy
Feb-21-20Initiated Guggenheim Buy $103
Jan-07-20Initiated Citigroup Buy $100
Aug-07-19Reiterated Canaccord Genuity Buy $96 → $125
Apr-16-19Initiated Canaccord Genuity Buy $90
Apr-10-19Upgrade BofA/Merrill Neutral → Buy $81 → $84
Feb-28-19Reiterated BofA/Merrill Neutral $42 → $60
Oct-29-18Initiated William Blair Outperform
Oct-29-18Initiated JP Morgan Overweight $42
Oct-29-18Initiated BofA/Merrill Neutral $37
Aug-07-20 02:25PM  
Aug-06-20 08:30PM  
06:07PM  
04:03PM  
Aug-02-20 06:46AM  
Jul-30-20 04:10PM  
12:33PM  
Jul-26-20 07:08AM  
Jul-22-20 11:30AM  
Jul-21-20 08:05AM  
Jul-19-20 07:03AM  
Jul-17-20 08:00AM  
Jul-13-20 01:12PM  
Jul-12-20 07:37PM  
Jul-08-20 12:09PM  
08:05AM  
Jul-05-20 07:07AM  
Jul-02-20 09:03AM  
Jun-23-20 07:55AM  
Jun-22-20 09:05AM  
Jun-16-20 04:30PM  
Jun-14-20 07:08AM  
Jun-13-20 08:10AM  
Jun-12-20 11:42AM  
Jun-08-20 04:03PM  
02:50PM  
Jun-01-20 10:32PM  
04:37PM  
May-29-20 04:03PM  
May-23-20 07:45AM  
May-15-20 08:05AM  
May-09-20 05:01PM  
May-08-20 04:27PM  
10:27AM  
May-07-20 04:03PM  
09:51AM  
May-06-20 04:03PM  
09:45AM  
May-05-20 08:05AM  
07:01AM  
May-02-20 10:35AM  
Apr-30-20 04:03PM  
Apr-10-20 08:39PM  
Apr-09-20 08:05AM  
Apr-03-20 01:10PM  
Mar-25-20 05:45PM  
Mar-23-20 10:46AM  
Mar-13-20 09:22AM  
Feb-26-20 08:34AM  
Feb-25-20 09:32AM  
08:58AM  
Feb-24-20 06:05PM  
04:03PM  
08:59AM  
Feb-20-20 10:47AM  
Feb-19-20 05:50PM  
09:50AM  
05:44AM  
Feb-17-20 12:30PM  
11:30AM  
Feb-14-20 10:49AM  
10:35AM  
09:18AM  
Feb-13-20 05:45PM  
Feb-12-20 08:10PM  
06:15PM  
Feb-11-20 09:22AM  
Feb-10-20 04:05PM  
Feb-04-20 06:41PM  
Jan-30-20 11:30AM  
10:15AM  
Jan-29-20 10:06AM  
Jan-24-20 05:50PM  
Jan-22-20 05:16PM  
Jan-21-20 08:30AM  
Jan-15-20 05:50PM  
Jan-13-20 05:23PM  
08:30AM  
Jan-12-20 08:00PM  
Jan-10-20 05:00AM  
Jan-01-20 10:44AM  
Dec-31-19 11:05AM  
11:01AM  
Dec-30-19 05:17PM  
04:05PM  
Dec-23-19 11:41AM  
11:30AM  
Dec-19-19 01:45PM  
Dec-18-19 12:56PM  
01:11AM  
Dec-16-19 11:51PM  
03:44PM  
Dec-13-19 08:15AM  
Dec-12-19 03:19PM  
02:34PM  
Dec-11-19 10:06AM  
08:15AM  
Dec-09-19 10:23AM  
05:27AM  
Dec-06-19 10:02AM  
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Talasaz AmirAliChairman, President and COOAug 04Option Exercise4.1815,00062,7002,704,532Aug 05 04:55 PM
Talasaz AmirAliChairman, President and COOAug 04Sale84.1915,0001,262,8772,689,532Aug 05 04:55 PM
Talasaz AmirAliChairman, President and COOAug 03Option Exercise4.1860,000250,8002,749,532Aug 05 04:55 PM
Talasaz AmirAliChairman, President and COOAug 03Sale86.2660,0005,175,7682,689,532Aug 05 04:55 PM
MERESMAN STANLEY JDirectorJul 10Option Exercise5.946,00035,64010,059Jul 14 05:00 PM
MERESMAN STANLEY JDirectorJul 10Sale86.666,000519,9604,059Jul 14 05:00 PM
Talasaz AmirAliChairman, President and COOJul 06Option Exercise4.1820,10884,0512,709,640Jul 06 08:12 PM
Talasaz AmirAliChairman, President and COOJul 06Sale84.1020,1081,691,0012,689,532Jul 06 08:12 PM
Talasaz AmirAliChairman, President and COOJul 02Option Exercise4.1854,892229,4492,744,424Jul 06 08:12 PM
Talasaz AmirAliChairman, President and COOJul 02Sale83.8754,8924,603,7942,689,532Jul 06 08:12 PM
CLARK IAN TDirectorJun 25Option Exercise4.185382,2495,181Jun 29 05:59 PM
CLARK IAN TDirectorJun 25Sale81.2753843,7234,643Jun 29 05:59 PM
MERESMAN STANLEY JDirectorJun 10Option Exercise5.946,00035,6407,302Jun 12 05:08 PM
MERESMAN STANLEY JDirectorJun 10Sale80.596,000483,5401,302Jun 12 05:08 PM
SVF Bluebird (Cayman) Ltd10% OwnerJun 08Sale83.161,162,50096,673,50014,037,960Jun 08 08:23 PM
SVF Bluebird (Cayman) Ltd10% OwnerJun 04Sale83.167,750,000644,490,00015,200,460Jun 08 08:23 PM
Talasaz AmirAliChairman, President and COOJun 03Option Exercise4.1855,000229,9002,744,532Jun 04 04:46 PM
CLARK IAN TDirectorJun 03Option Exercise4.182,69011,2443,992Jun 05 05:03 PM
CLARK IAN TDirectorJun 03Sale87.522,690235,4291,302Jun 05 05:03 PM
Talasaz AmirAliChairman, President and COOJun 03Sale85.6355,0004,709,4022,689,532Jun 04 04:46 PM
Talasaz AmirAliChairman, President and COOJun 02Option Exercise4.1820,00083,6002,709,532Jun 04 04:46 PM
Talasaz AmirAliChairman, President and COOJun 02Sale87.6320,0001,752,6732,689,532Jun 04 04:46 PM
CLARK IAN TDirectorMay 26Option Exercise4.185382,2491,840May 26 05:16 PM
CLARK IAN TDirectorMay 26Sale98.5053852,9931,302May 26 05:16 PM
BERTOCCI DEREK AChief Financial OfficerMay 22Option Exercise4.499,22241,42271,409May 26 05:17 PM
BERTOCCI DEREK AChief Financial OfficerMay 22Sale96.639,222891,14662,187May 26 05:17 PM
Nishar DipchandDirectorMay 18Sale100.0022002,321May 20 05:16 PM
Talasaz AmirAliChairman, President and COOMay 11Option Exercise4.186,00025,0802,889,483May 11 06:45 PM
MERESMAN STANLEY JDirectorMay 11Option Exercise5.946,50038,6107,802May 13 05:00 PM
BERTOCCI DEREK AChief Financial OfficerMay 11Sale92.5321,8622,022,89162,187May 12 05:02 PM
Talasaz AmirAliChairman, President and COOMay 11Sale91.68199,95118,332,3292,689,532May 11 06:45 PM
MERESMAN STANLEY JDirectorMay 11Sale86.506,500562,2501,302May 13 05:00 PM
Talasaz AmirAliChairman, President and COOMay 08Option Exercise4.187503,1352,908,532May 11 06:45 PM
BERTOCCI DEREK AChief Financial OfficerMay 08Sale90.4091382,53384,049May 12 05:02 PM
Talasaz AmirAliChairman, President and COOMay 08Sale90.1325,0492,257,6412,883,483May 11 06:45 PM
Talasaz AmirAliChairman, President and COOMay 07Option Exercise4.181,7627,3652,981,195May 11 06:45 PM
Talasaz AmirAliChairman, President and COOMay 07Sale83.3873,4136,121,0052,907,782May 11 06:45 PM
Talasaz AmirAliChairman, President and COOMay 06Option Exercise4.182,40010,0323,079,433May 06 06:20 PM
Talasaz AmirAliChairman, President and COOMay 06Sale81.24100,0008,123,6592,979,433May 06 06:20 PM
Talasaz AmirAliChairman, President and COOMay 05Option Exercise4.182,80011,7043,108,216May 06 06:20 PM
Talasaz AmirAliChairman, President and COOMay 05Sale78.8431,1832,458,3523,077,033May 06 06:20 PM
CLARK IAN TDirectorMay 04Option Exercise4.182,69011,2443,992May 06 06:20 PM
Talasaz AmirAliChairman, President and COOMay 04Option Exercise4.1813,43556,1583,169,387May 06 06:20 PM
Talasaz AmirAliChairman, President and COOMay 04Sale73.2263,9714,684,0963,105,416May 06 06:20 PM
CLARK IAN TDirectorMay 04Sale72.172,690194,1371,302May 06 06:20 PM
Talasaz AmirAliChairman, President and COOApr 29Option Exercise4.181,0404,3473,199,303Apr 30 06:09 PM
Wiley Michael JChief Legal OfficerApr 29Option Exercise4.183,78015,800114,951Apr 30 06:10 PM
Wiley Michael JChief Legal OfficerApr 29Sale80.113,780302,800111,171Apr 30 06:10 PM
Talasaz AmirAliChairman, President and COOApr 29Sale80.3343,3513,482,2943,155,952Apr 30 06:09 PM
Wiley Michael JChief Legal OfficerApr 28Option Exercise4.181,2205,100112,391Apr 30 06:10 PM
Talasaz AmirAliChairman, President and COOApr 28Option Exercise4.183141,3133,211,345Apr 30 06:09 PM
Talasaz AmirAliChairman, President and COOApr 28Sale80.2313,0821,049,5733,198,263Apr 30 06:09 PM
Wiley Michael JChief Legal OfficerApr 28Sale80.021,22097,628111,171Apr 30 06:10 PM
CLARK IAN TDirectorApr 27Option Exercise4.185382,2491,840Apr 29 05:00 PM
CLARK IAN TDirectorApr 27Sale77.5053841,6951,302Apr 29 05:00 PM
Wiley Michael JChief Legal OfficerApr 23Option Exercise4.185,00020,900116,171Apr 27 04:57 PM
Wiley Michael JChief Legal OfficerApr 23Sale77.325,000386,615111,171Apr 27 04:57 PM
Talasaz AmirAliChairman, President and COOApr 20Option Exercise4.182,72911,40773,789Apr 21 05:18 PM
Talasaz AmirAliChairman, President and COOApr 20Sale72.5610,270745,2353,139,971Apr 21 05:18 PM
Talasaz AmirAliChairman, President and COOApr 20Sale72.562,729198,02871,060Apr 21 05:18 PM
Talasaz AmirAliChairman, President and COOApr 17Option Exercise4.187,77132,48378,831Apr 21 05:18 PM
Talasaz AmirAliChairman, President and COOApr 17Sale72.7029,2302,125,0473,150,241Apr 21 05:18 PM
Talasaz AmirAliChairman, President and COOApr 17Sale72.707,771564,95971,060Apr 21 05:18 PM
Eltoukhy HelmyChief Executive OfficerApr 17Sale70.2215,9041,116,7393,174,980Apr 21 05:17 PM
Eltoukhy HelmyChief Executive OfficerApr 16Sale70.0120014,0013,190,884Apr 16 05:48 PM
CLARK IAN TDirectorApr 14Option Exercise4.182,68911,2403,991Apr 16 05:48 PM
Eltoukhy HelmyChief Executive OfficerApr 14Sale70.062,701189,2413,191,084Apr 16 05:48 PM
CLARK IAN TDirectorApr 14Sale70.002,689188,2301,302Apr 16 05:48 PM
MERESMAN STANLEY JDirectorApr 13Option Exercise5.949,50056,43010,802Apr 15 05:02 PM
MERESMAN STANLEY JDirectorApr 13Sale66.629,500632,8901,302Apr 15 05:02 PM
Talasaz AmirAliChairman, President and COOApr 02Option Exercise4.185,25021,94576,310Apr 06 05:02 PM
Talasaz AmirAliChairman, President and COOApr 02Sale67.035,250351,92271,060Apr 06 05:02 PM
Talasaz AmirAliChairman, President and COOApr 02Sale67.0319,7501,323,8953,179,471Apr 06 05:02 PM
Eltoukhy HelmyChief Executive OfficerMar 31Sale70.73103,1037,292,4143,193,785Apr 01 04:58 PM
Eltoukhy HelmyChief Executive OfficerMar 30Sale69.83178,09312,436,6933,296,888Apr 01 04:58 PM
CLARK IAN TDirectorMar 25Option Exercise4.185382,2491,840Mar 27 05:07 PM
CLARK IAN TDirectorMar 25Sale70.0053837,6601,302Mar 27 05:07 PM
BERTOCCI DEREK AChief Financial OfficerMar 24Option Exercise8.801141,00385,076Mar 25 05:13 PM
BERTOCCI DEREK AChief Financial OfficerMar 24Sale65.111147,42284,962Mar 25 05:13 PM
BERTOCCI DEREK AChief Financial OfficerMar 23Option Exercise4.6419,10088,612104,062Mar 25 05:13 PM
BERTOCCI DEREK AChief Financial OfficerMar 23Sale60.6519,1001,158,43384,962Mar 25 05:13 PM
Kaul SamirDirectorMar 04Sale82.3825,0002,059,54087,943Mar 06 05:52 PM
CLARK IAN TDirectorMar 03Option Exercise4.182,69011,2443,992Mar 04 05:03 PM
CLARK IAN TDirectorMar 03Sale78.332,690210,7081,302Mar 04 05:03 PM
CLARK IAN TDirectorFeb 25Option Exercise4.185382,2491,840Feb 27 04:32 PM
CLARK IAN TDirectorFeb 25Sale80.0053843,0401,302Feb 27 04:32 PM
MERESMAN STANLEY JDirectorFeb 13Option Exercise5.942,00011,8803,302Feb 18 04:33 PM
MERESMAN STANLEY JDirectorFeb 13Sale82.022,000164,0401,302Feb 18 04:33 PM
CLARK IAN TDirectorFeb 03Option Exercise4.182,69011,2443,992Feb 05 04:18 PM
CLARK IAN TDirectorFeb 03Sale76.232,690205,0591,302Feb 05 04:18 PM
CLARK IAN TDirectorJan 27Option Exercise4.185382,2491,840Jan 29 05:23 PM
CLARK IAN TDirectorJan 27Sale77.3153841,5931,302Jan 29 05:23 PM
MERESMAN STANLEY JDirectorJan 15Option Exercise5.945,00029,7006,302Jan 17 06:18 PM
MERESMAN STANLEY JDirectorJan 15Sale79.555,000397,7501,302Jan 17 06:18 PM
CLARK IAN TDirectorJan 03Option Exercise4.182,69011,2443,992Jan 07 05:54 PM
CLARK IAN TDirectorJan 03Sale77.872,690209,4701,302Jan 07 05:54 PM
CLARK IAN TDirectorDec 26Option Exercise4.185382,2491,840Dec 30 05:10 PM
CLARK IAN TDirectorDec 26Sale82.6953844,4871,302Dec 30 05:10 PM
Wiley Michael JChief Legal OfficerDec 23Option Exercise4.186,14825,699121,469Dec 26 04:36 PM
Wiley Michael JChief Legal OfficerDec 23Sale81.676,148502,098115,321Dec 26 04:36 PM